Quantification of Myocardial Fibrosis in Aortic Stenosis | MicrobiomeTrials← Back to trialsNCT06571175
Quantification of Myocardial Fibrosis in Aortic Stenosis
CompletedOBSERVATIONAL
Trial Details
Start: 2025-01-21Est. Completion: 2026-06-01
Enrollment target: 79 participants Locations- St. Olavs Hosptial, Trondheim, Trøndelag, Norway
Other microbiome trials you might be interested in
Aortic Valve Stenosis
Transcatheter aortic valve implantation (TAVI) is a key-hole technique to replace an aortic heart valve that is narrowed…
Aarhus, DenmarkEst. completion Dec 2027
CAD
Background:
Researchers are testing version of a system known as a magnetic resonance imagining (MRI) scanner that uses…
Bethesda, United StatesEst. completion May 31, 2028
Hypertrophic Cardiomyopathy
Left Ventricular Outflow Obstruction
Systolic Anterior Motion
This is an early study of a catheter-based minimally invasive procedure called SESAME to slice thick heart muscle as des…
Washington D.C., United StatesEst. completion Mar 1, 2029